Capricor Therapeutics Inc
(NAS:CAPR)
$
4.83
0.11 (2.33%)
Market Cap: 154.46 Mil
Enterprise Value: 116.56 Mil
PE Ratio: 0
PB Ratio: 8.28
GF Score: 60/100 Capricor Therapeutics Inc (CAPR) Transcripts
- Q1 2024 Capricor Therapeutics Inc Earnings Call TranscriptMay 13, 2024$5.44 (+2.64%)Earnings
- Q4 2023 Capricor Therapeutics Inc Earnings Call TranscriptFeb 29, 2024$4.2 (-3.00%)Earnings
- Capricor Therapeutics Inc Phase 3 Hope 3 Program Update TranscriptSep 29, 2023
- Q2 2023 Capricor Therapeutics Inc Earnings Call TranscriptAug 07, 2023$4.71 (+3.06%)Earnings
- Q1 2023 Capricor Therapeutics Inc Earnings Call TranscriptMay 11, 2023$4.11 (+0.74%)Earnings
- Q4 2022 Capricor Therapeutics Inc Earnings Call TranscriptMar 15, 2023$4.47 (-3.66%)Earnings
- Capricor Therapeutics Inc To Present 18-Month Data Results From Ongoing HOPE-2 Open Label Extension TranscriptJan 25, 2023
- Q3 2022 Capricor Therapeutics Inc Earnings Call TranscriptNov 10, 2022$4.9 (+4.03%)Earnings
- Capricor Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Q2 2022 Capricor Therapeutics Inc Earnings Call TranscriptAug 10, 2022$4.52 (-1.95%)Earnings
- Capricor Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptMay 25, 2022
- Q1 2022 Capricor Therapeutics Inc Earnings Call TranscriptMay 10, 2022$3.24 (+3.69%)Earnings
- Q4 2021 Capricor Therapeutics Inc Earnings & Recent Corporate Update Call TranscriptMar 10, 2022
- Capricor Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Capricor Therapeutics Inc Earnings Call TranscriptAug 12, 2021$4.48 (+1.59%)Earnings
- Q1 2021 Capricor Therapeutics Inc Earnings Call TranscriptMay 13, 2021$3.16 (-6.78%)Earnings
- Q4 2020 Capricor Therapeutics Inc Earnings Call TranscriptMar 11, 2021$5.54 (+1.84%)Earnings
- Q3 2020 Capricor Therapeutics Inc Earnings Call TranscriptNov 12, 2020$4.65 (-0.85%)Earnings
- Capricor Therapeutics Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 12, 2020
- Capricor Therapeutics Inc Overview of CAP-1002 in Patients with Duchenne Muscular Dystrophy TranscriptSep 02, 2020
- Q2 2020 Capricor Therapeutics Inc Earnings Call TranscriptAug 06, 2020$7.9 (-3.66%)Earnings
- Q1 2020 Capricor Therapeutics Inc Earnings Call TranscriptMay 14, 2020$6.55 (-1.65%)Earnings
- Capricor Therapeutics Inc to Discuss the Top-Line Results of the HOPE-2 Study - Call TranscriptMay 13, 2020
- Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call on CAP-1002 TranscriptApr 15, 2020
- Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call TranscriptMar 26, 2020
- Q4 2019 Capricor Therapeutics Inc Earnings Call TranscriptMar 18, 2020$1.12 (-4.27%)Earnings
- 1